US 7345060
Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
granted A61KA61K31/439A61K31/445
Quick answer
US patent 7345060 (Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity) held by Theravance, Inc. expires Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Mar 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/439, A61K31/445, A61K31/4545, A61P